Bumgardner G L, Li J, Apte S, Heininger M, Frankel W L
Department of Surgery, The Ohio State University, Columbus, USA.
Hepatology. 1998 Aug;28(2):466-74. doi: 10.1002/hep.510280226.
Adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) have been implicated in the pathogenesis of various inflammatory liver disease states, including viral and autoimmune hepatitis as well as liver allograft rejection. Tumor necrosis factor alpha (TNF-alpha) is an inflammatory cytokine known to up-regulate adhesion molecules as well as major histocompatibility complex (MHC) class I expression, and has been demonstrated to be important in the rejection of vascularized organ allografts. The current studies address the effect of TNF-alpha and the role of ICAM-1 expression on liver cell immunogenicity in vitro in mixed lymphocyte hepatocyte culture (MLHC), in vitro in mixed lymphocyte liver nonparenchymal cell culture (MLNPC), in vivo in hepatocyte sponge matrix allografts (HC-SMA), and in vivo in liver nonparenchymal cell sponge matrix allografts (NPC-SMA). Purified allogeneic hepatocytes (HC) and liver nonparenchymal cells (NPC) under naive, unstimulated conditions demonstrated different profiles of MHC antigen and adhesion molecule expression, but both liver cell populations stimulated the proliferation and development of allospecific cytotoxic effectors in vitro and in vivo. Despite significant up-regulation of MHC class I and ICAM-1 on both HC and liver NPCs by in vivo treatment with TNF-alpha, the immunogenicity of TNF-alpha-stimulated liver cells was not appreciably different from naive, unstimulated liver cells. In contrast, ICAM-1-negative HC and NPCs were significantly less immunogenic both in terms of lymphocyte proliferative responses and the generation of allospecific cytolytic effectors. These results suggest that constitutive expression of ICAM-1 enhances the immunogenicity of "donor" liver cells but is not absolutely required to elicit immune responses to allogeneic liver cells. Further studies to determine the role of adhesion molecule expression on trafficking of host immune cells to the liver and the role of adhesion molecule expression by host cells are required to clarify their role in immune responses to liver cells.
细胞间黏附分子-1(ICAM-1)和血管细胞黏附分子-1(VCAM-1)等黏附分子与多种炎症性肝病的发病机制有关,包括病毒性和自身免疫性肝炎以及肝移植排斥反应。肿瘤坏死因子α(TNF-α)是一种炎症细胞因子,已知可上调黏附分子以及主要组织相容性复合体(MHC)I类表达,并已证明在血管化器官同种异体移植的排斥反应中起重要作用。目前的研究探讨了TNF-α的作用以及ICAM-1表达在体外混合淋巴细胞肝细胞培养(MLHC)、体外混合淋巴细胞肝非实质细胞培养(MLNPC)、体内肝细胞海绵基质同种异体移植(HC-SMA)和体内肝非实质细胞海绵基质同种异体移植(NPC-SMA)中对肝细胞免疫原性的影响。在未受刺激的天然条件下,纯化的同种异体肝细胞(HC)和肝非实质细胞(NPC)表现出不同的MHC抗原和黏附分子表达谱,但两种肝细胞群体在体外和体内均刺激同种异体特异性细胞毒性效应细胞的增殖和发育。尽管通过TNF-α体内治疗,HC和肝NPC上的MHC I类和ICAM-1均显著上调,但TNF-α刺激的肝细胞的免疫原性与未受刺激的天然肝细胞没有明显差异。相比之下,ICAM-1阴性的HC和NPC在淋巴细胞增殖反应和同种异体特异性溶细胞效应细胞的产生方面免疫原性显著降低。这些结果表明,ICAM-1的组成性表达增强了“供体”肝细胞的免疫原性,但并非引发对同种异体肝细胞免疫反应的绝对必要条件。需要进一步研究以确定黏附分子表达在宿主免疫细胞向肝脏迁移中的作用以及宿主细胞黏附分子表达的作用,以阐明它们在对肝细胞免疫反应中的作用。